Free Streaming News
Membership is Free
What are you waiting for? Sign up now!
already have an account?
I bet you can't wait to get back in here...
Username or email:
need an account?
Benzinga - Feed Your Mind.
Best of Benzinga
From The Press
Trading Strategies & Education
Tickers, Articles & Keywords:
Search by keyword...
The Countdown to October 16 Begins for Vringo and Google
08/20/2012 - 12:45pm
There are less than two months left until Vringo (NYSE: VRNG) and Google (NASDAQ: GOOG) go head-to-head in court.
In-Depth Look at ChromaDex and Its Clinical Results
06/13/2012 - 5:41pm
ChromaDex (OTC: CDXC) released positive clinical safety data today on its flagship ingredient, pTeroPure. ChromaDex is traded on the over-the-counter markets and saw heavy volume following the news, despite closing the session unchanged in price.
ChromaDex's Nicotinamide Riboside Discussed in 'Cell Metabolism'
06/06/2012 - 4:39pm
June 6, 2012 - Cell Press:
Vivus' Qnexa Is Not Guaranteed Approval. Remember Provenge?
05/31/2012 - 12:52pm
Dear Vivus (NASDAQ: VVUS) investors: You are paying $2.5 billion for a company with zero profits in a market space valued at only $3.5 billion annually.
Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
05/29/2012 - 8:30am
It should come as no surprise that our government is yet again neglecting the food supply. The U.S.
Get Benzinga's News
Zing Talk: Daily Top Stories
See More »
Weekly ETF Outlook
Daily Ratings Summary
Benzinga's M&A Chatter for Tuesday June 18, 2013
Texas Industries Names Tom Ransdell Chairman
Symmetricom Announces Strategic Restructuring Plan
Emerging Markets Awash in Protests
UPDATE: Oppenheimer Initiates Coverage on Neurocrine Biosciences on Potential Elagolix Success
Adobe Trades Higher on Q2 Results (ADBE)
Mylan Looking to Raise Pact from $1.25B to $1.5B
From Smithfield Proxy: Co. Considered 'Potentially Significant' Deal in Packaged-Meats Sector
13D Filing from Amgen on Cytokinetics Shows Raised 7.58% Stake, Had Shown 2.34% as of Feb. 29th, 2012
Dell Special Committee Responds to Carl Icahn's Latest Offer, Says Still Recommends $13.65/Share Deal
NVIDIA Says Will Begin Licensing GPU Technology
UPDATE: Tetra Tech Shares Fall 10% After-Hours on Lowered Guidance
UPDATE: Tetra Tech Slashes Q3 Guidance, Board Authorizes $100M Buyback Plan
Tetra Tech Resumes Trading
American Capital Agency Cuts Qtr. Dividend from $1.25 to $1.05/Share
Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content.
Be Your Own Boss
Tools & Features
Real Time Feed
Submit News Tips
In the News
Terms and Conditions
1 (877) 440-9464 (ZING)
Benzinga.com © 2013